Holen Sie sich die Stockscreener-App
1.35
3.57%
-0.05
Handel nachbörslich:
1.36
0.01
+0.74%
Vivani Medical Inc Aktie (VANI) Neueste Nachrichten
Form 8K Vivani Medical Inc For: 17 August By Investing.com - Investing.com Canada
Vivani Medical posts slide presentation under Reg FD; Exhibit 99.1 attached - TradingView
Wall Street Zen Upgrades Vivani Medical (NASDAQ:VANI) to "Hold" - MarketBeat
Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal - foreignpolicyjournal.com
Vivani Medical Fully Enrolls Phase 1 Semaglutide Implant Trial; Data Due November - Minichart
Form 8K Vivani Medical Inc For: 13 August By Investing.com - Investing.com Nigeria
Vivani Medical (NASDAQ:VANI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Vivani Medical Q2 Results: EPS beats estimate, losses narrow 41% YoY - scanx.trade
Vivani Medical: Q2 Earnings Snapshot - AOL.com
Vivani Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update - Yahoo Finance
Vivani Medical (VANI) widens GLP‑1 pipeline, funds runway into Q2 2027 - Stock Titan
ClearOne (CLRO) details Cortigent reverse merger, 78% Vivani control and new equity plan - Stock Titan
ClearOne to merge with Cortigent, pivoting to neurotech under new Nasdaq ticker - Dealroom
Vivani Medical Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
ClearOne Inc. (CLRO) majority holder cancels warrant as Cortigent merger proceeds - Stock Titan
Form 8K Vivani Medical Inc For: 6 August By Investing.com - Investing.com Nigeria
Vivani Medical Completes Enrollment, Dosing in Phase 1 SLIM-1 Trial - marketscreener.com
Vivani Completes Enrollment in SLIM-1 Semaglutide Implant Trial - TipRanks
Form 8K Vivani Medical Inc For: 6 August - Investing.com India
Semaglutide implant trial doses all 20 participants; data expected in November - Stock Titan
ClearOne Cancels 437,500 First Finance Warrants at $5.00 Amid Cortigent Merger Process - TradingView
Vivani Medical (VANI) to Announce Earnings on Wednesday - MarketBeat
Enterprise value to EBITDA forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Vivani Medical, Inc. Revenue Breakdown – NASDAQ:VANI - TradingView
Form 4 Vivani Medical Inc For: 30 July By Investing.com - Investing.com Nigeria
Vivani Medical (VANI) awards CEO 200K stock options and 100K RSUs - Stock Titan
Vivani Medical (NASDAQ: VANI) grants COO options and performance RSUs - Stock Titan
Vivani Medical (VANI) awards 70,000 options and 35,000 RSUs to CBO - Stock Titan
Form 4 Vivani Medical Inc For: 28 July By Investing.com - Investing.com Canada
Vivani Medical, Inc. (VANI) awards stock options in lieu of director fees - Stock Titan
Vivani Medical (VANI) Slides Nearly 8% as Shares Approach Key SupportPrice Momentum Stocks - dars.gov.et
Vivani Medical Market Sentiment - Benzinga España
Vivani Medical Inc. Revenue Breakdown – FWB:U5P - TradingView
Vivani Medical Inc (VANI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - Bernama
Vivani Medical Inc (VANI) Cash Flow - TradingKey
Vivani Medical Inc (VANI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vivani Medical Inc (VANI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to revenue forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Enterprise value to revenue forward of Vivani Medical Inc. – FWB:U5P - TradingView
Enterprise value to EBITDA forward of Vivani Medical Inc. – FWB:U5P - TradingView
ClearOne (CLRO) to acquire Cortigent, cede control to Vivani in stock deal - Stock Titan
Vivani Medical Highlights Upcoming SLIM-1 First Dosing Milestone - TipRanks
Form 4 Vivani Medical Inc For: 16 July By Investing.com - Investing.com Nigeria
Vivani Medical (NASDAQ: VANI) Targets August Human Trial For Semaglutide Implant Following Novo Nordisk Evaluation Deal - foreignpolicyjournal.com
New Form 4! Biggun at that! Hehehe - Moomoo
Vivani Medical director Gregg Williams buys $1m in stock - Investing.com UK
Vivani Medical director Gregg Williams buys $1m in stock By Investing.com - Investing.com Australia
Vivani Medical (NASDAQ: VANI) insider buys 793,650 shares at $1.26 - Stock Titan
Vivani Medical says first SLIM-1 dosing expected in August 2026 after CEO presentation - TradingView
Vivani Medical at emerging growth conference: implant push gains traction By Investing.com - Investing.com South Africa
Vivani Medical (VANI) Emerging Growth Conference Summary - Quartr
Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal - MarketBeat
Vivani Medical at emerging growth conference: implant push gains traction - Investing.com
Vivani Medical (VANI) Edges Lower in Light Trading as Support Level Comes into FocusBreakout Trade - dars.gov.et
1.80%
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):